| |
 |
|
Class Information
Number: 424/190.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same > Disclosed amino acid sequence derived from bacterium (e.g., mycoplasma, anaplasma, etc.)
Description: Subject matter wherein the disclosed amino acid sequence is derived from a bacterial protein or fragment thereof.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7371394 |
Antigenic composition of a Pseudomonas aeruginosa protein |
May. 13, 2008 |
| 7371821 |
Cloning and expression of the full length 110 kDa antigen of Orientia tsutsugamushi to be used as a vaccine component against scrub typhus |
May. 13, 2008 |
| 7368261 |
Conserved Neisserial antigens |
May. 6, 2008 |
| 7364729 |
Method of inducing a CTL response |
Apr. 29, 2008 |
| 7364740 |
Molecular differences between species of the M. tuberculosis complex |
Apr. 29, 2008 |
| 7361353 |
Immunisation against Chlamydia trachomatis |
Apr. 22, 2008 |
| 7357932 |
Surface protein of Neisseria bacteria |
Apr. 15, 2008 |
| 7344724 |
UspA1 and UspA2 antigens of Moraxella catarrhalis |
Mar. 18, 2008 |
| 7341727 |
M. catarrhalis outer membrane protein-106 polypeptide, methods of eliciting an immune response comprising same |
Mar. 11, 2008 |
| 7341843 |
Botulinum toxin A peptides and methods of predicting and reducing immunoresistance to botulinum toxin therapy |
Mar. 11, 2008 |
| 7335368 |
BVH-A2 and BVH-A3 antigens of group B Streptococcus |
Feb. 26, 2008 |
| 7335370 |
Chlamydia antigens and corresponding DNA fragments and uses thereof |
Feb. 26, 2008 |
| 7332172 |
Transformed bacteria producing CS6 antigens as vaccines |
Feb. 19, 2008 |
| 7332171 |
Ehrlichia chaffeensis 28 kDa outer membrane protein multigene family |
Feb. 19, 2008 |
| 7329500 |
Moraxella (Branhamella) catarrhalis polypeptides and corresponding DNA fragments |
Feb. 12, 2008 |
| 7326545 |
Chlamydia antigens and corresponding DNA fragments and uses thereof |
Feb. 5, 2008 |
| 7326419 |
Surface protein of Leptospira |
Feb. 5, 2008 |
| 7323175 |
Immunogenicity of glucan binding protein |
Jan. 29, 2008 |
| 7323179 |
Methods and compositions for the treatment and prevention of Staphylococcus and other bacterial infections |
Jan. 29, 2008 |
| 7320794 |
Transporter protein |
Jan. 22, 2008 |
| 7314632 |
Pseudomonas exotoxin A-like chimeric immunogens |
Jan. 1, 2008 |
| 7314625 |
Chimeric protein comprising non-toxic Pseudomonas exotoxin A and Type IV pilin sequences |
Jan. 1, 2008 |
| 7311917 |
Moraxella catarrhalis protein, gene sequence and uses thereof |
Dec. 25, 2007 |
| 7311922 |
Fusion proteins of mycobacterium tuberculosis |
Dec. 25, 2007 |
| 7306805 |
Nontypeable Haemophilus influenzae virulence factors |
Dec. 11, 2007 |
| 7306808 |
Orientia tsutsugamushi truncated recombinant outer membrane protein (r47) and (r57) vaccines diagnostics and therapeutics for scrub typhus |
Dec. 11, 2007 |
| 7304139 |
Polynucleotides and polypeptides of Anaplasma phagocytophilum and methods of using the same |
Dec. 4, 2007 |
| 7297341 |
Chlamydia antigens and corresponding DNA fragments and uses thereof |
Nov. 20, 2007 |
| 7297340 |
Vaccine and method for preventing biofilm formation |
Nov. 20, 2007 |
| 7291722 |
Polypeptide from haemophilus influenza |
Nov. 6, 2007 |
| 7288261 |
Mid-life vaccine and methods for boosting anti-mycobacterial immunity |
Oct. 30, 2007 |
| 7285276 |
Chlamydia antigens and corresponding DNA fragments and uses thereof |
Oct. 23, 2007 |
| 7279170 |
32-kDa protein derived from Mycobacterium tuberculosis and related peptides |
Oct. 9, 2007 |
| 7273611 |
Proteinase K resistant surface protein of neisseria meningitidis |
Sep. 25, 2007 |
| 7273605 |
Vaccine |
Sep. 25, 2007 |
| 7270827 |
Multivalent streptococcal vaccine compositions and methods for use |
Sep. 18, 2007 |
| 7261897 |
Fusion proteins of mycobacterium tuberculosis |
Aug. 28, 2007 |
| 7261900 |
Recombinant modified Bacillus anthracis protective antigen for use in vaccines |
Aug. 28, 2007 |
| 7256265 |
Streptococcal C5a peptidase vaccine |
Aug. 14, 2007 |
| 7250172 |
Vaccine and compositions for the prevention and treatment of neisserial infections |
Jul. 31, 2007 |
| 7247308 |
Streptococcus pyogenes antigens |
Jul. 24, 2007 |
| 7247306 |
Bacteria strain and bacteriocin produced therefrom |
Jul. 24, 2007 |
| 7241449 |
Transferrin receptor genes of moraxella |
Jul. 10, 2007 |
| 7238359 |
Antigen ORF Rv2430c and a method thereof |
Jul. 3, 2007 |
| 7235242 |
IgA1 protease fragment as carrier peptides |
Jun. 26, 2007 |
| 7232569 |
Type III secretion pathway in aeromonas salmonicida, and uses therefor |
Jun. 19, 2007 |
| 7229622 |
Synthetic chimeric fimbrin peptides |
Jun. 12, 2007 |
| 7226597 |
Mutants of Clostridium difficile toxin B and methods of use |
Jun. 5, 2007 |
| 7223412 |
Staphylococcal enterotoxin SEC-SER, expression vector and host cell, production method thereof, and manufacturing method of vaccine |
May. 29, 2007 |
| 7223836 |
Peptides for chlamydophila pneumoniae vaccine and diagnosis |
May. 29, 2007 |
|
|
|
